Publication Name	World Journal of Immunology
Manuscript ID	69504
Country	Bulgaria

Received	2021-07-02 05:55
Peer-Review Started	2021-07-02 05:58
To Make the First Decision
Return for Revision	2021-07-30 03:36
Revised	2021-08-13 21:16
Second Decision	2022-07-22 07:47
Accepted by Journal Editor-in-Chief
Accepted by Company Editor-in-Chief	2022-07-25 03:32
Articles in Press	2022-07-25 03:32
Publication Fee Transferred
Edit the Manuscript by Language Editor	2022-07-19 03:46
Typeset the Manuscript	2022-08-21 22:48
Publish the Manuscript Online	2022-08-22 12:18

ISSN	2219-2824 (online)
Open Access
Copyright	©The Author(s) 2022. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com

Category	Immunology
Manuscript Type	Editorial
Article Title	Vaccines and autoimmunity during the COVID-19 pandemic
Manuscript Source	Invited Manuscript
All Author List	Tsvetelina Velikova
Funding Agency and Grant Number
Corresponding Author	Tsvetelina Velikova, MD, PhD, Assistant Professor, Department of Clinical Immunology, University Hospital Lozenetz, Kozyak 1 Street, Sofia 1407, Bulgaria. tsvelikova@medfac.mu-sofia.bg
Key Words	SARS-CoV-2; COVID-19; immune response; COVID-19 vaccine; immune memory; autoimmunity; autoimmune diseases; relapse
Core Tip	Coronavirus disease 2019 (COVID-19) vaccines have created concerns about their efficacy and safety, notably in autoimmune patients. Which vaccine adverse events are related to the underlying autoimmunity is unclear. Additional data is needed to evaluate the immunological impact of COVID-19 vaccines in terms of effectiveness and immune-driven adverse effects that might provoke a disease flare in individuals with a history of autoimmune-related symptoms. However, the risk of autoimmune disease flare after vaccination was considered low, while the immune responses after vaccination showed great immunogenicity for these patients. In addition, vaccination will considerably decrease related morbidity and mortality from COVID-19 in autoimmune patients.
Publish Date	2022-08-22 12:18
Citation	Velikova T. Vaccines and autoimmunity during the COVID-19 pandemic. World J Immunol 2022; 12(2): 9-14
URL	https://www.wjgnet.com/2219-2824/full/v12/i2/9.htm
DOI	https://dx.doi.org/10.5411/wji.v12.i2.9

Full Article (PDF)	WJI-12-9.pdf
Full Article (Word)	WJI-12-9.docx
Manuscript File	69504_Auto_Edited-JJW-Filipodia-LS.docx
Answering Reviewers	69504-Answering reviewers.pdf
Audio Core Tip	69504-Audio core tip.m4a
Conflict-of-Interest Disclosure Form	69504-Conflict-of-interest statement.pdf
Copyright License Agreement	69504-Copyright license agreement.pdf
Non-Native Speakers of English Editing Certificate	69504-Language certificate.pdf
Peer-review Report	69504-Peer-review(s).pdf
Scientific Misconduct Check	69504-Bing-Wang JJ-2.png
Scientific Editor Work List	69504-Scientific editor work list.pdf